Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis

Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study

(2016) Béranger Lueza et al.   PLoS One

On the restricted mean survival time curve in survival analysis

(2015) Lihui Zhao et al.   BIOMETRICS

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

(2015) Pierre Blanchard et al.   LANCET ONCOLOGY

Bias and precision of measures of survival gain from right-censored data

(2015) Karen E. Lamb et al.   PHARMACEUTICAL STATISTICS

Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data

(2015) Yinghui Wei et al.   STATISTICS IN MEDICINE

Testing the treatment effect on competing causes of death in oncology clinical trials

(2014) Federico Rotolo et al.   BMC Medical Research Methodology

Adjusting for centre heterogeneity in multicentre clinical trials with a time-to-event outcome

(2014) Marco Munda et al.   PHARMACEUTICAL STATISTICS

Permutation tests for centre effect on survival endpoints with application in an acute myeloid leukaemia multicentre study

(2014) L. Biard et al.   STATISTICS IN MEDICINE

Predicting the restricted mean event time with the subject's baseline covariates in survival analysis

(2013) L. Tian et al.   BIOSTATISTICS

Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome

(2013) Patrick Royston et al.   BMC Medical Research Methodology

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

(2013)   LANCET

Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data

(2013) Nicholas R. Latimer   MEDICAL DECISION MAKING

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves

(2012) Patricia Guyot et al.   BMC Medical Research Methodology

Asymptotic properties of mean survival estimate based on the Kaplan-Meier curve with an extrapolated tail

(2012) Qi Gong et al.   PHARMACEUTICAL STATISTICS

Statistical Analysis of Individual Participant Data Meta-Analyses: A Comparison of Methods and Recommendations for Practice

(2012) Gavin B. Stewart et al.   PLoS One

Two-stage meta-analysis of survival data from individual participants using percentile ratios

(2012) Jessica K. Barrett et al.   STATISTICS IN MEDICINE

Individual patient data meta-analysis of time-to-event outcomes: one-stage versus two-stage approaches for estimating the hazard ratio under a random effects model

(2012) Jack Bowden et al.   Research Synthesis Methods

Network meta-analysis of survival data with fractional polynomials

(2011) Jeroen P Jansen   BMC Medical Research Methodology

The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt

(2011) Patrick Royston et al.   STATISTICS IN MEDICINE

Survival Time Outcomes in Randomized, Controlled Trials and Meta-Analyses: The Parallel Universes of Efficacy and Cost-Effectiveness

(2011) Patricia Guyot et al.   VALUE IN HEALTH

Network meta-analysis of parametric survival curves

(2011) Mario J. N. M. Ouwens et al.   Research Synthesis Methods

Survival Models in Health Economic Evaluations: Balancing Fit and Parsimony to Improve Prediction

(2010) Christopher H Jackson et al.  

One-stage parametric meta-analysis of time-to-event outcomes

(2010) F. Siannis et al.   STATISTICS IN MEDICINE

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

(2009) Jean-Pierre Pignon et al.   RADIOTHERAPY AND ONCOLOGY

Pseudo-observations in survival analysis

(2009) Per Kragh Andersen et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Simpson's paradox visualized: The example of the Rosiglitazone meta-analysis

(2008) Gerta Rücker et al.   BMC Medical Research Methodology

Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach

(2007) V. Rondeau et al.   STATISTICS IN MEDICINE